{"id":"W4391130620","doi":"10.1007/s40257-024-00846-3","title":"Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Placebo; Internal medicine; Alopecia areata; Adverse effect; Cohort; Gastroenterology; Incidence (geometry); Surgery; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001646437,0.0002620945,0.002734267,0.0002129,0.00006540339,0.00002434423,0.0004129969,0.0002173907,0.00009689036],"category_scores_gemma":[0.002364761,0.0001250267,0.00221883,0.001033702,0.001904602,0.0000750151,0.00003203751,0.0005730756,0.000003558256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000303336,"about_ca_system_score_gemma":0.000902137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004610927,"about_ca_topic_score_gemma":0.0004277444,"domain_scores_codex":[0.9937571,0.001242381,0.003945655,0.0003655187,0.000369902,0.0003194131],"domain_scores_gemma":[0.9867355,0.01096925,0.0008938716,0.0005935316,0.0004721981,0.0003356642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05184553,0.003821601,0.04342944,0.00001409,0.007798554,0.0001693042,0.0003866439,0.00001098177,0.00001119485,0.0001497999,0.002550686,0.8898122],"study_design_scores_gemma":[0.04669924,0.04107394,0.109149,0.0001604264,0.01532735,0.0001165361,0.005328837,0.00770215,0.00006623595,0.0002435989,0.7738904,0.0002422729],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987424,0.00221228,0.002137486,0.005766906,0.001056152,0.0009433709,0.0003001267,0.00002589936,0.0001337683],"genre_scores_gemma":[0.9916782,0.00308145,0.003148025,0.001118743,0.0007187882,0.00003414321,0.0001785448,0.00002775482,0.00001430123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8895699,"threshold_uncertainty_score":0.7017586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1100982298020965,"score_gpt":0.4678687888651819,"score_spread":0.3577705590630854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}